Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 2
Below are the questions for the exam with the choices of answers:
Question #1
A Probenecid reduces allergic reactions to amoxicillin. Probenecid enhances the antibacterial action of amoxicillin.
B Probenecid reduces allergic reactions to amoxicillin. Probenecid enhances the antibacterial action of amoxicillin. Probenecid prevents the renal excretion of amoxicillin.
C Combination therapy is beneficial to the patient. Probenecid prevents the renal excretion of amoxicillin. Probenecid increases the duration of action of amoxicillin.
D Probenecid reduces allergic reactions to amoxicillin. Probenecid increases the duration of action of amoxicillin. Probenecid enhances the antibacterial action of amoxicillin.
Question #2
A Prophylactic
B Empiric
C Supplemental
D Maintenance
Question #3
A Shortened duration of drug actions
B Delay in drug absorption
C Decreased pharmacologic effects of drugs
D Development of drug toxicity
Question #4
A Rash
B Urticaria
C Anaphylactic shock
D Hypotension
Question #5
A Obtain a prescription for an oral formulation without altering the dose.
Explain to the patient that the drug becomes inactive if it is taken orally.
B Explain to the patient that the drug causes toxic effects if it is taken orally.
Obtain a prescription for an oral formulation without altering the dose.
C Obtain a prescription for an enteric-coated oral formulation to prevent inactivation in the liver.
Obtain a prescription for an oral formulation without altering the dose.
D Explain to the patient that the drug becomes inactive if it is taken orally.
Explain to the patient that the drug will have a reduced effect if it is taken orally.
Question #6
A It will become zero.
B It will be increased.
C It will be decreased.
D It will be unaffected.
Question #7
A Intranasal, Intraocular, and Transdermal
B Injection into the portal vein and Transdermal
C Injection into the portal vein and Oral
D Intranasal, Injection into the portal vein and Oral
Question #8
A Initiate therapy with a lower-than-recommended dose.
B Increase the dose from the recommended dose.
C Prescribe an antibiotic with a low therapeutic index.
D Administer the antibiotic with diuretic medications.
Question #9
A Grapefruit
B Spinach
C Yogurt
D Cheese
Question #10
A Enteric-coated tablet
B Capsule
C Oral suspension
D Elixir
Question #11
A Administering the medication via the Z-track method
B Massaging the site after injection
C Lowering the extremity below the level of the heart
D Applying cold packs to the injection site
Question #12
A The therapeutic index of the drug may have been high.
B The patient may have taken an excess dose of the drug.
C The patient may have taken the drug with grapefruit juice.
D The patient may have a deficiency of drug-metabolizing enzymes.
Question #13
A Acetaminophen
B Amoxicillin
C Ibuprofen
D Warfarin
Question #14
A Palliative
B Empiric
C Prophylactic
D Maintenance
Question #15
A Dissolve the granules in a beverage.
B Chew the granules in the capsule.
C Open the capsule and sprinkle the granules on soft food.
D Crush the capsule.
Question #16
A “I should avoid giving the patient milk.”
B “I should avoid giving the patient green leafy vegetables.”
C “I should avoid giving the patient orange juice.”
D “I should avoid giving the patient aged cheese.”
Question #17
A “Take the drug with iron-rich foods like spinach.”
B “Take the drug with vitamin supplements.”
C “Avoid taking the drug with milk.”
D “Take an antacid with the drug.”
Question #18
A There is a high possibility that overdose events will occur.
B The chances of side effects are low with this drug relative to other drugs.
C The drug will have low tolerance when compared with other drugs.
D There is less possibility of developing dependence.
Question #19
A A large percentage of an intravenously administered drug is metabolized into inactive metabolites in the liver.
B Medications given orally bypass the portal circulatory system.
C Drugs administered intravenously enter the portal system before systemic distribution.
D Medications given intravenously are not affected by the first-pass effect.
Question #20
A The drug should be taken with large amounts of food. The drug should be crushed before administration.
B Anticholinergic drugs may negate the effect of the enteric coating. Dissolution of the drug in the stomach is prevented.
C Absorption of the drug in the intestine is prevented.The drug should be taken with large amounts of food.
D The drug should be crushed before administration. Absorption of the drug in the intestine is prevented.
Question #21
A Hemolysis of platelets
B Hemolysis of white blood cells
C Hemolysis of red blood cells
D Bone marrow suppression
Question #22
A It negates the action of the drug.
B It reduces the metabolism of the drug.
C It increases excretion of the drug.
D It chemically binds to the drug.
Question #23
A 60 mg/L
B 50 mg/L
C 20 mg/L
D 10 mg/L
Question #24
A 50 mg/L
B 40 mg/L
C 25 mg/L
D 75 mg/L
Question #25
A Intramuscularly
B Intravenously
C Intrathecally
D Subcutaneously
Question #26
A Pharmaceutics
B Pharmacokinetics
C Pharmacodynamics
D Pharmacotherapeutics
Question #27
A Receptor interaction
B Selective interaction
C Enzyme interaction
D Nonselective interaction
Question #28
A Elixir
B Oral soluble wafer
C Powder
D Suspension
Question #29
A Formation of active metabolites is high in bile.
B Formation of inactive metabolites is high in feces.
C Formation of inactive metabolites is low in the kidneys.
D Formation of inactive metabolites is high in the liver.
Question #30
A Mucosal cells
B White blood cells
C Platelets
D Red blood cells
Question #31
A Drug interaction
B Pharmacologic
C Allergic
D Idiosyncratic
Question #32
A Palliative
B Supplemental
C Prophylactic
D Maintenance
Question #33
A Altering metabolic chemical processes. Making the cell perform a new function
B Interacting with receptors. Altering metabolic chemical processes. Inhibiting the action of a specific enzyme
C Altering metabolic chemical processes. Inhibiting the action of a specific enzyme. Making the cell perform a new function
D None of these
Question #34
A Subcutaneous
B Rectal
C Sublingual
D Oral
Question #35
A Resection of the small intestine
B Seizure disorder
C Left lower leg amputation
D Coronary artery bypass graft
Question #36
A Additive
B Adverse
C Synergistic
D Antagonistic
Question #37
A Administration with 8 ounces of water is required.
B The risk of drug–drug interactions is increased.
C The duration of action is typically short.
D The effect is decreased in patients with a low albumin level.
Question #38
A Ptyalin
B P450 enzymes
C Gastric lipase
D Pancreatic lipase
Question #39
A Contraindication
B Idiosyncratic reaction
C Drug interaction
D Allergy
Question #40
A Palliative
B Supplemental
C Maintenance
D Acute
Question #41
A Physiologic interactions of drugs
B Distribution rates among various body compartments
C Adverse reactions to medications
D Interactions among various drugs
Question #42
A Acute
B Supportive
C Maintenance
D Supplemental
Question #43
A Antagonistic
B Synergistic
C Incompatibility
D Additive
Question #44
A Be eliminated by the body
B Reach a therapeutic level
C Be absorbed by the body
D Exert a response
Question #45
A Oral
B Intravenous
C Sublingual
D Subcutaneous
Question #46
A 70%
B 50%
C 60%
D 100%
Question #47
A Mouse
B Rabbit
C Horse
D Pig
Question #48
A Tolerance
B Therapeutic index
C Dependence
D Addiction
Question #49
A Absorption
B Metabolism
C Excretion
D Dilution
Question #50
A Dermatologic
B Immune
C Circulatory
D Nervous
Question #51
A Oral
B Transdermal
C Rectal
D Topical